News

Moderna says flu shot more effective than rival GSK in late-stage study
Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...
FierceBiotech6h
Moderna's mRNA flu vaccine beats approved competitor in latest phase 3 win, teeing up push to FDA
The latest phase 3 win is a boost for Moderna’s attempts to create a flu/COVID combination vaccine. The company withdrew a filing for FDA approval for its combo candidate last month while it waited ...
BioSpace10h
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...
NBC New York14h
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and ...
STAT14h
Pharmalittle: We’re reading about a Moderna flu vaccine, a J&J loss over 340B rebate plans, and more
Stay tuned. We hope your day is simply smashing and, as always, do keep in touch if something tantalizing emerges. … Moderna disclosed that a study of 56,000 volunteers older than 50 found that its ...
Reuters14h
Moderna's experimental flu vaccine more effective than approved shot in study
June 30 (Reuters) - Moderna (MRNA.O), opens new tab said on Monday its experimental influenza vaccine was found to be 26.6% more effective than a currently approved annual flu shot when tested in ...